Christopher Chiles, MD
Basic profileBaylor Scott & White Medical Center - Temple
Christopher Chiles is a Cardiology physician affiliated with Baylor Scott & White Medical Center - Temple. OpenAlex indexes 24 publications with 380 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2401 S 31st St
Temple, TX 765080001
Telephone
254-724-2111Provider last certified this registry record 13 Jan 2021.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20252 payments
- Abbott LaboratoriesProgram year20251 payment
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.9%Statin20.9%Atorvastatin Calcium66%Rosuvastatin Calcium34%Part D≥48 patientsBeta blocker17%Carvedilol45%Metoprolol Succinate34%Metoprolol Tartrate21%Part D≥29 patients+ 12 more classes in this area
Blood & clotting
10.9%Factor Xa inhibitor7.9%Eliquis100%Part D≥26 patientsP2Y12 inhibitor3%Clopidogrel100%Part D≥11 patientsMetabolism & gastrointestinal
4.3%SGLT2 inhibitor4.3%Jardiance100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Outcomes for Patients Undergoing Revascularization for Multivessel Acute Coronary Syndrome at High‐Volume and Non‐High‐Volume Hospitals
Catheterization and Cardiovascular Interventions
2025 - 100.49 Stents, Scalpel, or Stability: Revascularization in Patients Over 75 With Acute Coronary Syndrome
JACC: Cardiovascular Interventions
2025 - Acute Coronary Syndrome Revascularization Strategies With Multivessel Coronary Artery Disease
The American Journal of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Tavilla, MD, PhD
Baylor Scott & White Medical Center - Temple
Tariq Shafi, MD
Baylor Scott & White Medical Center - Temple
Shekhar Ghamande, MD
Baylor Scott & White Medical Center - Temple
Lazaros Nikolaidis, MD
Baylor Scott & White Medical Center - Temple
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”